Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2018 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEWS CORP NEW | 4 | Q3 2023 | 44.4% |
NEWS CORP NEW | 4 | Q3 2023 | 20.5% |
THERAVANCE BIOPHARMA INC | 4 | Q3 2023 | 10.3% |
SOTERA HEALTH CO | 4 | Q3 2023 | 4.7% |
BANDWIDTH INC | 4 | Q3 2023 | 3.8% |
ARCONIC CORPORATION | 3 | Q2 2023 | 3.6% |
BLACKLINE INC | 3 | Q3 2023 | 2.8% |
DIGITAL RLTY TR INC | 3 | Q3 2023 | 2.5% |
ISHARES TR RUSSELL 2000 ETF | 2 | Q1 2023 | 15.4% |
ISHARES TR RUSSELL 2000 ETF | 2 | Q3 2023 | 10.5% |
View Irenic Capital Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-04-26 |
SC 13D/A | 2024-03-07 |
SC 13D/A | 2024-02-28 |
DFAN14A | 2024-02-16 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13D | 2024-01-29 |
SC 13D | 2023-12-20 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
View Irenic Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.